2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$309.25$0.00 (0.00%)
Price as of Jul 14, 2026 4:14 AM EDT- $6.3BMarket Cap
- 143.66%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$309.25$0.00 (0.00%)
LGND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $309.25 | ||
Change | -$6.99 (-2.21%) | ||
Open | $315.09 | ||
High | $316.42 | ||
Low | $304.77 | ||
Previous Close | $316.24 | ||
Volume | 245,725 | ||
30-Day Average Volume | 600,080 | ||
1-Week Change | -3.49% | ||
1-Month Change | 21.02% | ||
1-Year Change | 143.66% | ||
3-Year Change | 351.66% | ||
5-Year Change | 153.53% | ||
Fundamentals | |||
Shares Outstanding | 20.0M | ||
Total Assets | $1.5B | ||
Market Cap | $6.3B | ||
Enterprise Value | $7.2B | ||
Period: QTR TTM FY | |||
Revenue | $32.9M | ||
Net Income | -$13.3M | ||
Free Cash Flow | $48.5M | ||
EBIT | -$22.7M | ||
EBITDA | -$14.4M | ||
Net Working Capital | $824.7M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -500 | ||
Enterprise Value/Revenue | 219 | ||
P/B | 6 | ||
P/E | -472 | ||
PEG | 4 | ||
Price/Free Cash Flow | 131 | ||
Price/Operating Cash Flow | 130 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/02/2010 | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 11/19/2010 | ||
Earnings & Revenue